HPV Self-Collection for Cervical Cancer: Dr. Kay’s Insights
In this episode of OncoDaily, Dr. Carolyn Kay, MD, an obstetrician-gynecologist and Global Medical Affairs Lead at Roche Diagnostics, joins host Emma Ter-Azaryan to discuss the FDA-approved HPV self-collection solution. Dr. Kay explores how this groundbreaking approach enhances access to cervical cancer screening, particularly for underserved communities. She highlights its accuracy, reliability, and potential to overcome barriers such as geographic limitations, cultural concerns, and personal experiences.
Carolyn Kay, MD, is an obstetrician-gynecologist with a focus on cervical pre-cancer and cancer, racial disparities in cervical cancer screening, reproductive health, and the use of digital technology to address unmet needs in women’s health. As the global medical affairs lead supporting oncology assays at Roche Diagnostics, she is a contributor to the global movement to eliminate cervical cancer while working to move the needle on physician education and health literacy in historically excluded communities.
Dr. Kay earned her medical degree at the SUNY Upstate Medical University and completed residency training at Hofstra-Northwell Health in New York.
00:00 Introduction
02:32 HPV Self-Collection Explained
05:22 HPV Self-Collection & Accessibility
07:15 HPV Self-Collection Process & Accuracy
08:55 HPV Self-Collection: Clinical Data & Effectiveness
11:00 Addressing Doubts in HPV Screening
12:17 HPV Self-Collection vs. Traditional Tests
13:50 Cancer Screenings for Underserved Communities
15:10 Encouraging HPV Self-Collection Screening
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023